Campbell & Co Investment Adviser’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
+20,745
| New | +$1.62M | 0.1% | 304 |
|
|
2024
Q4 | – | Sell |
-3,084
| Closed | -$204K | – | 1138 |
|
|
2024
Q3 | $204K | Buy |
+3,084
| New | +$204K | 0.02% | 1014 |
|
|
2023
Q4 | – | Sell |
-3,434
| Closed | -$238K | – | 1168 |
|
|
2023
Q3 | $238K | Sell |
3,434
-415
| -11% | -$28.8K | 0.03% | 799 |
|
|
2023
Q2 | $363K | Buy |
+3,849
| New | +$363K | 0.06% | 580 |
|
|
2023
Q1 | – | Sell |
-3,205
| Closed | -$239K | – | 874 |
|
|
2022
Q4 | $239K | Buy |
+3,205
| New | +$239K | 0.06% | 627 |
|
|
2019
Q2 | – | Sell |
-8,589
| Closed | -$548K | – | 576 |
|
|
2019
Q1 | $548K | Buy |
+8,589
| New | +$548K | 0.27% | 93 |
|
|
2017
Q4 | – | Sell |
-30,291
| Closed | -$1.1M | – | 432 |
|
|
2017
Q3 | $1.1M | Buy |
+30,291
| New | +$1.1M | 0.89% | 9 |
|
|
2017
Q2 | – | Sell |
-10,950
| Closed | -$343K | – | 337 |
|
|
2017
Q1 | $343K | Buy |
+10,950
| New | +$343K | 0.89% | 38 |
|
|
2014
Q3 | – | Sell |
-22,164
| Closed | -$317K | – | 209 |
|
|
2014
Q2 | $317K | Buy |
+22,164
| New | +$317K | 0.13% | 139 |
|